SAN DIEGO, Jan. 4, 2018 /PRNewswire/ — Avelas Biosciences, Inc., a clinical stage oncology-focused company that is developing products to advance a new standard-of-care for cancer surgery and therapeutic intervention, today announced the completion of Period 1 patient enrollment in its…
